Sight Sciences (SGHT) COO Alison Bauerlein awarded 127,512 RSUs in stock grant

Rhea-AI Filing Summary

Sight Sciences Chief Operating Officer Alison Bauerlein received a grant of 127,512 restricted stock units (RSUs) of common stock on February 3, 2026. The RSU award size is based on $825,000 divided by the closing price of the stock on the grant date.

The RSUs vest in 16 equal quarterly installments from March 31, 2026 through December 31, 2029, contingent on continued service. After this grant, Bauerlein beneficially owns 727,495 shares of common stock, including 135,620 shares and 591,875 shares underlying unvested RSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bauerlein Alison

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A		127,512(1)	A	$0	727,495(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $825,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026.

2. Includes (i) 135,620 shares of Common Stock, and (ii) 591,875 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SGHT Chief Operating Officer Alison Bauerlein report?

Alison Bauerlein reported receiving 127,512 restricted stock units of Sight Sciences common stock as a stock-based compensation grant. The award was made under the 2021 Incentive Award Plan on February 3, 2026, at no cash cost per share to her.

How was the size of Alison Bauerlein’s RSU grant at Sight Sciences (SGHT) determined?

The number of RSUs granted to Alison Bauerlein was calculated by dividing $825,000 by the closing price of Sight Sciences common stock on February 3, 2026. This formula set the 127,512-unit award under the company’s 2021 Incentive Award Plan.

What is the vesting schedule for Alison Bauerlein’s new SGHT RSUs?

The 127,512 RSUs vest in 16 equal quarterly installments starting March 31, 2026 and ending December 31, 2029. Each vesting date requires Bauerlein’s continued service, and each vested RSU converts into one share of Sight Sciences common stock.

How many Sight Sciences (SGHT) shares does Alison Bauerlein beneficially own after this Form 4?

After the reported grant, Alison Bauerlein beneficially owns 727,495 shares of Sight Sciences common stock. This includes 135,620 actual shares and 591,875 shares that will be issued upon future vesting and settlement of outstanding RSUs.

Does Alison Bauerlein’s reported SGHT transaction involve a stock purchase or sale?

The filing shows an acquisition of 127,512 shares in the form of RSUs granted at a price of $0 per share. It reflects stock-based compensation rather than an open-market purchase or sale of Sight Sciences common stock.

What plan governs the RSU grant to SGHT executive Alison Bauerlein?

The RSU grant to Alison Bauerlein was made under Sight Sciences’ 2021 Incentive Award Plan. This plan allows the company to issue equity-based awards, such as restricted stock units, as part of executive and employee compensation packages.